New Delhi, June 24, 2026 : Advik Laboratories rights issue has been temporarily halted after a Delhi court granted an ad-interim ex parte injunction, restraining the company from proceeding with its proposed capital raise pending further judicial examination.

Author: Aadarsh Patel | EQMint

The interim order marks an early legal setback for the company’s management headed by Vikas Garg and comes in response to a suit filed by Fairplan Distributors Pvt. Ltd., a significant shareholder in the company.

Court Grants Interim Injunction

The Patiala House Courts observed that a prima facie case existed and granted interim relief, preventing Advik Laboratories and certain defendants from taking further steps in relation to the proposed rights issue until further orders.

As part of the interim order, the company has been restrained from:

• Filing regulatory documents related to the issue
• Circulating the Letter of Offer or other offer documents
• Accepting subscriptions from shareholders
• Allotting shares under the proposed rights issue
• Proceeding with key stages of the fundraising exercise

The court clarified that the injunction is an interim measure and does not amount to a final determination of the dispute.

Shareholder Raises Governance Concerns

The legal challenge was initiated by Fairplan Distributors Pvt. Ltd., which alleged that despite multiple fundraising exercises undertaken by the company in recent years, concerns remain regarding the utilization of funds and broader corporate governance practices.

These allegations have not yet been adjudicated, and the court has not expressed any final opinion on their merits.

However, the court noted that allowing the rights issue to proceed before the dispute is examined could result in irreversible consequences, justifying interim protection.

What Happens Next?

The litigation now moves into the next phase, where Vikas Garg and the other defendants will have an opportunity to file their responses and contest the allegations before the court.

The matter has been listed for further hearing on August 22, 2026, when the court is expected to hear arguments from both sides before deciding on the continuation or modification of the interim relief.

Why It Matters For Investors

Rights issues are commonly used by listed companies to raise additional capital from existing shareholders. A judicial stay on such a process can delay fundraising plans and create uncertainty regarding future corporate actions.

Investors will likely monitor:

• Future court proceedings
• Any regulatory disclosures by the company
• Management’s response to the allegations
• The eventual outcome of the shareholder dispute

EQMint Analysis on Advik Laboratories rights issue

The Delhi court’s interim order does not establish wrongdoing by Advik Laboratories or its management. Instead, it preserves the status quo while the legal issues are examined.

Nevertheless, the case highlights the growing importance of shareholder activism and corporate governance in India’s listed company ecosystem. The eventual ruling could have implications not only for Advik Laboratories’ fundraising plans but also for how courts approach shareholder challenges to major corporate actions in the future.

Until the matter is decided, the proposed rights issue will remain on hold, making this one of the closely watched corporate governance disputes in the small-cap space.

FAQ

Why has Advik Laboratories’ rights issue been stayed?

The Delhi court granted an interim injunction after a shareholder challenged the proposed rights issue and raised governance-related concerns.

Who filed the case?

The suit was filed by Fairplan Distributors Pvt. Ltd., a significant shareholder of Advik Laboratories.

Has the court found Advik Laboratories guilty?

No. The court has only granted interim relief and has not expressed any final view on the allegations.

What has the court restrained?

The company has been restrained from proceeding with key stages of the rights issue, including regulatory filings, offer documents, subscription acceptance and share allotment.

When is the next hearing?

The matter is scheduled for further hearing on August 22, 2026.

For more such information visit EQMint

Join our Whatsapp channel for timely updates: Whatsapp

Disclaimer:  This article is not an investment advice and is for educational purpose only.